Effectiveness of yoga for major depressive disorder: A systematic review and meta-analysis

被引:10
|
作者
Wu, Yufei [1 ]
Yan, Danni [1 ]
Yang, Jianli [1 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Psychol, Tianjin, Peoples R China
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
关键词
major depressive disorder; depression; anxiety; yoga; systematic review; TREATMENT-RESISTANT DEPRESSION; REDUCE PRENATAL DEPRESSION; LIFE-STYLE INTERVENTION; IYENGAR YOGA; KRIYA-YOGA; ANTIDEPRESSANT EFFICACY; POSITION STATEMENT; PHYSICAL-ACTIVITY; HATHA YOGA; EXERCISE;
D O I
10.3389/fpsyt.2023.1138205
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Major depressive disorder (MDD) has a relapse rate that cannot be ignored and places a tremendous burden on the patient in the prevention and treatment process. Yoga, a combination of physical and mental exercises, is effective and acceptable for the adjunctive treatment of MDD. This study aimed to explore further the evidence of yoga's efficacy for patients with MDD. Methods: PubMed, Embase, Cochrane library, PsycINFO, SinoMed, CNKI, Wanfang, and VIP databases from their inception to 13 October 2022 were searched by a pre-defined search strategy. RCTs of patients with MDD who met diagnostic criteria for yoga treatment were included. RoB2.0 was used to evaluate the quality of the literature. Improvement in depressive symptoms was assessed by the Beck Depression Inventory (BDI), Hamilton Depression Rating Scale (HAMD), or other scales were used as primary outcome indicators, and improvement in anxiety was assessed by the Hamilton Anxiety Scale (HAMA) and State-Trait Anxiety Inventory (STAI) scale as secondary outcome indicators. RR and Cohen's d at 95% CI were used as effect size estimates, and Q and I-2 were used to evaluate the size of heterogeneity, with a p-value less than 0.05 indicating statistical significance. Results: Thirty-four RCT studies, including 1,269 patients in the treatment group and 1,072 patients in the control group, 48.4% of whom were women, were included in the study. Compared to the control group, the BDI-II results yielded a moderate effect of yoga on the improvement of depressive symptoms (Cohen's d=-0.60; 95% CI: -1.00 to -0.21; p<0.01), the HAMD results yielded a moderate improvement of yoga on the severity of depressive symptoms (Cohen's d=-0.64; 95% CI: -0.98 to -0.30; p<0.01), and the STAI results can be concluded that yoga had a negligible effect on the improvement of the level of anxiety (Cohen's d=-0.26; 95% CI: -0.48 to -0.04; p=0.02). No adverse events occurred in the yoga group during the treatment. Conclusion: Yoga can improve depressive symptoms and anxiety in patients with MDD and has a safe and wide patient acceptance.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] The effectiveness of mindfulness yoga on patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials
    Chuyuan Miao
    Yun Gao
    Xiaohua Li
    Ying Zhou
    Joanne Wai-yee Chung
    Graeme D. Smith
    [J]. BMC Complementary Medicine and Therapies, 23
  • [2] The effectiveness of mindfulness yoga on patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials
    Miao, Chuyuan
    Gao, Yun
    Li, Xiaohua
    Zhou, Ying
    Chung, Joanne Wai-yee
    Smith, Graeme D.
    [J]. BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [3] Effectiveness of family psychoeducation for major depressive disorder: systematic review and meta-analysis
    Katsuki, Fujika
    Watanabe, Norio
    Yamada, Atsurou
    Hasegawa, Takaaki
    [J]. BJPSYCH OPEN, 2022, 8 (05):
  • [4] A systematic review of yoga for major depressive disorder
    Cramer, Holger
    Anheyer, Dennis
    Lauche, Romy
    Dobos, Gustav
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2017, 213 : 70 - 77
  • [5] Adjunctive cariprazine for major depressive disorder: a systematic review and meta-analysis
    Gill, Hartej
    Chen-Li, David C. J.
    Haikazian, Sipan
    Seyedin, Sam
    McIntyre, Roger S.
    Mansur, Rodrigo B.
    DiVincenzo, Joshua D.
    Phan, Lee
    Rosenblat, Joshua D.
    [J]. CNS SPECTRUMS, 2024, 29 (04) : 233 - 242
  • [6] Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis
    Kennis, Mitzy
    Gerritsen, Lotte
    van Dalen, Marije
    Williams, Alishia
    Cuijpers, Pim
    Bockting, Claudi
    [J]. MOLECULAR PSYCHIATRY, 2020, 25 (02) : 321 - 338
  • [7] Epidemiology of Major Depressive Disorder in Iran: A Systematic Review and Meta-Analysis
    Sadeghirad, Behnam
    Haghdoost, Ali-Akbar
    Amin-Esmaeili, Masoumeh
    Ananloo, Esmaeil Shahsavand
    Ghaeli, Padideh
    Rahimi-Movaghar, Afarin
    Talebian, Elham
    Pourkhandani, Ali
    Noorbala, Ahmad Ali
    Barooti, Esmat
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2010, 1 (02) : 81 - 91
  • [8] Comorbid Major Depressive Disorder in Schizophrenia: A Systematic Review and Meta-Analysis
    Etchecopar-Etchart, Damien
    Korchia, Theo
    Loundou, Anderson
    Llorca, Pierre-Michel
    Auquier, Pascal
    Lancon, Christophe
    Boyer, Laurent
    Fond, Guillaume
    [J]. SCHIZOPHRENIA BULLETIN, 2021, 47 (02) : 298 - 308
  • [9] Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis
    Ahmad, Abdullah
    Awan, Abdul Rafeh
    Nadeem, Natasha
    Javed, Aamir Shahid
    Farooqi, Mobeen
    Daniyal, Muhammed
    Mumtaz, Hassan
    [J]. FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [10] Gut microbiota and major depressive disorder: A systematic review and meta-analysis
    Sanada, Kenji
    Nakajima, Shinichiro
    Kurokawa, Shunya
    Barcelo-Soler, Alberto
    Ikuse, Daisuke
    Hirata, Akihito
    Yoshizawa, Akira
    Tomizawa, Yoshihiro
    Salas-Valero, Montserrat
    Noda, Yoshihiro
    Mimura, Masaru
    Iwanami, Akira
    Kishimoto, Taishiro
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2020, 266 : 1 - 13